FDA to Monitor Advertising
The Food and Drug Administration will begin to monitor how pharmaceutical companies advertise their drugs. This follows an overall expansion of the social sciences at the FDA. Furthermore, the monitoring also appears to be a response to the controversy surrounding Merck and their drug Vioxx.